Skip to main content

Closed

PULM: Pulmatrix, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-100.0% / yr

Operating margin0.0%

ROIC-128.5%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio4.96×

Pulmatrix, Inc.

PULMNASDAQ Capital Market·USD·Closed

Pulmatrix, Inc.

PULMNASDAQ·USD·Closed

$1.74

+2.35%

$1.74

+$0.04 (2.35%)

52W Range

13thpctl

Volume

0.33×avg

Mkt Cap

6.35MUSD

P/E

-1.4TTM

Div Yield

–ann

52W Range

13thpctl

Volume

0.33×avg

Market Cap

6.35MUSD

P/E Ratio

-1.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings